Endoscopy 2024; 56(S 02): S85-S86
DOI: 10.1055/s-0044-1782874
Abstracts | ESGE Days 2024
Oral presentation
Diagnosis and therapy in the esophagus: What's new? 26/04/2024, 14:00 – 15:00 Room 8

Feasibility, safety, and outcomes of UGI endoscopic submucosal dissection from UK ESD Registry: The largest multicentre prospective study on Western population

H. Htet
1   Queen Alexandra Hospital, Portsmouth, United Kingdom
,
K. Siggens
1   Queen Alexandra Hospital, Portsmouth, United Kingdom
,
S. Subramaniam
1   Queen Alexandra Hospital, Portsmouth, United Kingdom
,
G. Longcroft-Wheaton
1   Queen Alexandra Hospital, Portsmouth, United Kingdom
,
F. Thursby-Pelham
1   Queen Alexandra Hospital, Portsmouth, United Kingdom
,
A. Alkandari
1   Queen Alexandra Hospital, Portsmouth, United Kingdom
,
M. Baker-Moffatt
1   Queen Alexandra Hospital, Portsmouth, United Kingdom
,
J. White
2   Nottingham University Hospitals NHS – City Hospital, Nottingham, United Kingdom
,
P. B. Adolfo
2   Nottingham University Hospitals NHS – City Hospital, Nottingham, United Kingdom
,
M. Banks
3   University College London Hospitals Nhs Foundation Trust, London, United Kingdom
,
J. E. East
4   Translational Gastroenterology Unit, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom
,
N. Suzuki
5   Wolfson Unit for Endoscopy, St Mark's Hospital, London, United Kingdom
,
B. Saunders
5   Wolfson Unit for Endoscopy, St Mark's Hospital, London, United Kingdom
,
A. Haji
6   King's College Hospital, London, United Kingdom
,
B. Hayee
6   King's College Hospital, London, United Kingdom
,
P. Bhandari
1   Queen Alexandra Hospital, Portsmouth, United Kingdom
› Author Affiliations
 

Aims The outcome of ESD in early gastrointestinal neoplasia in Japan is well established whereas in the west, it is variable depending on the volume and experience. Therefore, a multicentre national registry was set up in the UK to prospectively evaluate the practice and outcomes of ESD.

Methods This is a prospective observational study for patients undergoing ESD for early GI neoplasia. All technical and outcoms data was prospectively collected onto REDCap.

Results There were 451 UGI ESD cases recruited between August 2016 to August 2023 from 6 large tertiary referral centres in the UK. Mean age of the patients was 70.8 years (range: 24-94 years) with male preponderance (318 males vs. 133 females). Majority were in oesophagus: 282 (62.53%), stomach: 159 (35.25%) and duodenum: 10 (2.22%).

Of 282 oesophageal ESDs, 277 (98.23%) were technically successful with en-bloc resection rate of 96%. There were 3 intraprocedural complications (2 oesophageal perforations and 1 oral laceration from overtube). All of them were managed endoscopically. There were 29 (10.28%) post ESD strictures requiring endoscopic dilatations. 3 (1.06%) delayed bleeding were noted and 3 were readmitted for decompensation of underlying co-morbidities.

There were 204/282 (72.34%) Barrett’s cases with average length of C2.9 M4.9. 34 cases (16.67%) had previous ESD or ablation at the same site. Post ESD resection showed deep SM invasion in 21 patients (deep R0 achieved in 42.9% and lateral R0 in 76.2%), 23 pT1bSM1 (deep R0 in 87.0% and lateral R0 in 87%), 107 pT1a (deep R0 in 89.7% and lateral R0 in 85.1%), 31 HGD (R0 in 97%) and 9 LGD (R0 in 78%).

There were 44 SCC, 26 gastro-oesophageal junctional neoplasia and 8 others (submucosal lesion and granular cell tumours). Of 44 SCC, there were 8 pT1b (5 achieved deep R0, 7 achieved lateral R0), 10 pT1a (all achieved both deep and lateral R0), 22 HGD (81.8% achieved R0), 3 LGD (all achieved R0).

There were 160 gastric ESDs with completion rate of 96.25% and en-bloc rate of 95.5%. There were 8 (5%) intra-procedural perforation which required endoscopic clippings. There were 7 (4.36%) delayed bleeds which were managed endoscopically. Of 160 cases, 138 were epithelial neoplasia, 11 were submucosal lesions while 4 were large hyperplastic polyps. Of 138 epithelial neoplasia, 10 had deep SM invasion (7 achieved deep R0, 8 lateral R0), 14 pT1bSM1 (7 achieved deep R0, 10 lateral R0), 50 pT1a (90% achieved deep R0, 80% lateral R0), 35 HGD (94.3% R0) and 27 LGD (77.8% R0).

Conclusions Unlike in the East, most ESDs in our study were performed in the oesophagus rather than the stomach. Our data demonstrates the feasibility and safety of UGI ESD in Western setting with very low complication rates without requiring surgical intervention. We found that deep submucosal invasion is a strong predictor of poor R0 rate.



Publication History

Article published online:
15 April 2024

© 2024. European Society of Gastrointestinal Endoscopy. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany